Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial.
We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.
Phase:
PHASE4
Details
Lead Sponsor:
Western University, Canada
Collaborators:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Queen Elizabeth II Health Sciences Centre St. Michael's Hospital (Toronto, Canada)